close

Marksans Pharma Ltd

Know More
NSEBSE

109.55-0.50 (-0.45%)

03:59 PM,3rd Oct 2023

109.60-0.35 (-0.32%)

04:01 PM,3rd Oct 2023

BSE : 524404

NSE : MARKSANS

Sector : Health care

ISIN Code : INE750C01026

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Oct 03 2023 | 04:01 PM IST

Market Cap (₹ Cr)

4964

Turnover (₹ Cr)

1.92

Volume (Shares)

1751491

Face Value

1

52-WK High

122.50

52-WK High Date

10 Aug 2023

52-WK Low

45.40

52-WK Low Date

29 Sep 2022

All Time High

122.50

All Time High Date

10 Aug 2023

All Time Low

0.87

All Time Low Date

28 May 2003

Marksans Pharma Ltd

Marksans Pharma Limited is a public limited company incorporated in the year April 16th 1982. The Company is primarily engaged in the business of research manufacture marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna Goa and R & D center in Navi Mumbai.The Company on 30th March 2015 issued and allotted 24006494 equity shares of Rs1/- each to qualified institutional buyers under QIP for cash at Rs54.67 (including premium) per Equity Share. In accordance to terms of issue the Directors in their meeting held on 7th February 2015 decided to redeem entire 1350000 7% Redeemable Cumulative Preference Shares of face value Rs100/- per share at par out of profits in tranches before due date of redemption i.e 27th March 2018. Accordingly on 7th February 2015 the Directors redeemed 100000 preference shares at par.The Company issued 50000 Bonds of USD 1000 each in principal value during the financial year 2015. As on date of report the Company bought back and extinguished 49939 Bonds. Of which only 61 Bonds of USD 1000 each in principal value (out of total 50000 Bonds issued) remained outstanding as the same are not traceable During the year 2017 the Company redeemed 150000 preference shares of Rs100/-each at par. Accordingly issued subscribed and paid-up preference share capital reduced from 1250000 preference shares of Rs100/- each to 1100000 preference shares of Rs100/- each with effect from 31st March 2017.

Marksans Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

4964

EPS - TTM (₹) [S]

2.82

P/E Ratio (X) [S]

4.47

Face Value (₹) 1
Latest Dividend (%)50.00
Latest Dividend Date 07 Jun 2023
Dividend Yield (%) 0.45
Book Value Share (₹) [S]24.52
P/B Ratio (₹) [S]4.47
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Quant Small Cap Fund - (G) 136.07 12041259 1.69
Quant Small Cap Fund - (IDCW) 136.07 12041259 1.69
Quant Small Cap Fund - Direct (G) 136.07 12041259 1.69
Quant Small Cap Fund - Direct (IDCW) 136.07 12041259 1.69
Quant Business Cycle Fund - Regular (G) 6.78 600000 1.59
Quant Business Cycle Fund - Regular (IDCW) 6.78 600000 1.59
Quant Business Cycle Fund - Direct (G) 6.78 600000 1.59
Quant Business Cycle Fund - Direct (IDCW) 6.78 600000 1.59
Motilal Oswal Nifty Microcap 250 Index Fund-Reg (G) 1.71 151442 0.53
Motilal Oswal Nifty Microcap 250 Index Fund-Dir (G) 1.71 151442 0.53

Load more

Research Reports

Date BrokerActionPrices(Rs)Report
01-12-2022HDFC Securities Buy 56.2

Stock Strength

Today's Low/High

107.35

111.45

Week Low/High

103.75

111.45

Month Low/High

100.00

114.00

Year Low/High

45.40

123.00

All time Low/High

0.71

123.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week3.40%3.30%-0.66-0.69%
1 Month-1.57%-1.62%0.190.48%
3 Month18.14%18.11%0.471.07%
6 Month53.20%53.22%10.8412.25%
1 Year136.61%136.35%15.3615.64%
3 Year112.10%111.90%69.2971.05%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
15-06-2021CRONY VYAPAR PVT LTDNSEBUY290017293.75
15-06-2021CRONY VYAPAR PVT LTDNSESELL280017293.69
15-06-2021GRAVITON RESEARCH CAPITAL LLPNSEBUY300427993.18
15-06-2021GRAVITON RESEARCH CAPITAL LLPNSESELL300427993.09
14-06-2021GRAVITON RESEARCH CAPITAL LLPNSESELL477225092.37
14-06-2021GRAVITON RESEARCH CAPITAL LLPNSEBUY477225092.29
14-06-2021PARTH INFIN BROKERS PVT LTDNSEBUY301173394.60
14-06-2021PARTH INFIN BROKERS PVT LTDNSESELL302673394.88
14-06-2021VAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITEDNSESELL275554590.91
14-06-2021VAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITEDNSEBUY275554590.87

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter43.85
Financial Institutions Banks0.00
Foreign Institutional Investors4.02
Insurance Companies0.00
Mutual Funds Uti2.79
Other Institutional Investors11.75
Indian Public32.37
Others Non Institutional Investors5.22
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairman & Managing Director : Mark Saldanha

Company Sec. & Compli. Officer : Harshavardhan Panigrahi

Non-Exec. & Independent Dir. : Seetharama Raju Buddharaju

Whole-time Director : Sandra Saldanha

Non-Exec. & Independent Dir. : Digant Mahesh Parikh

Whole-time Director : Varddhman Vikramaditya Jain

Non-Exec. & Independent Dir. : Abhinna Sundar Mohanty

Independent Director : Meena Rani Surana

Director : Sunny Sharma

Registered Office: 11th Flr GRANDEUR Oshiwara, Veera Desai Extn Rd Andheri(W),Mumbai,Maharashtra-400053 Ph: 91-22-40012000

Email:companysecretary@marksanspharma.com

URL:http://www.marksanspharma.com